Literature DB >> 10049293

Fosfomycin alters lipopolysaccharide-induced inflammatory cytokine production in mice.

T Matsumoto1, K Tateda, S Miyazaki, N Furuya, A Ohno, Y Ishii, Y Hirakata, K Yamaguchi.   

Abstract

To determine the mechanisms of immunomodulating action of fosfomycin (FOF), we examined its effect on the production of inflammatory cytokines in mice injected with lipopolysaccharide (LPS). Treatment with FOF significantly lowered the peak serum levels of tumor necrosis factor alpha and interleukin-1 beta, indicating that FOF alters inflammatory cytokine production after LPS stimulation.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10049293      PMCID： PMC89186     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Adverse effects of tumour necrosis factor in cyclophosphamide-treated mice subjected to gut-derived Pseudomonas aeruginosa sepsis.

Authors:  T Matsumoto; K Tateda; S Miyazaki; N Furuya; A Ohno; Y Ishii; Y Hirakata; K Yamaguchi
Journal:  Cytokine       Date:  1997-10       Impact factor: 3.861

2.  Modulatory effect of antibiotics on cytokine production by human monocytes in vitro.

Authors:  K Morikawa; H Watabe; M Araake; S Morikawa
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

3.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

4.  Paradoxical synergistic effects of tumour necrosis factor and interleukin 1 in murine gut-derived sepsis with Pseudomonas aeruginosa.

Authors:  T Matsumoto; K Tateda; S Miyazaki; N Furuya; A Ohno; Y Ishii; Y Hirakata; K Yamaguchi
Journal:  Cytokine       Date:  1999-05       Impact factor: 3.861

5.  Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice.

Authors:  T Matsumoto; K Tateda; S Miyazaki; N Furuya; A Ohno; Y Ishii; Y Hirakata; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

6.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

7.  Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1.

Authors:  D Wallach; H Holtmann; H Engelmann; Y Nophar
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

8.  Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.

Authors:  T Matsumoto; K Tateda; N Furuya; S Miyazaki; A Ohno; Y Ishii; Y Hirakata; K Yamaguchi
Journal:  J Med Microbiol       Date:  1998-04       Impact factor: 3.196

9.  Mortality rates amongst mice with endogenous septicaemia caused by Pseudomonas aeruginosa isolates from various clinical sources.

Authors:  N Furuya; Y Hirakata; K Tomono; T Matsumoto; K Tateda; M Kaku; K Yamaguchi
Journal:  J Med Microbiol       Date:  1993-08       Impact factor: 3.196
  9 in total
  7 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

3.  Pretreatment of mice with clindamycin improves survival of endotoxic shock by modulating the release of inflammatory cytokines.

Authors:  N Hirata; K Hiramatsu; K Kishi; T Yamasaki; T Ichimiya; M Nasu
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

4.  Immunomodulatory effects of fosfomycin in experimental human endotoxemia.

Authors:  Robert Sauermann; Claudia Marsik; Ilka Steiner; Katja Seir; Tuende Cvitko; Markus Zeitlinger; Oswald Wagner; Christian Joukhadar
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

5.  Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages.

Authors:  Tetsuji Nakano; Kazufumi Hiramatsu; Kenji Kishi; Norio Hirata; Jun-Ichi Kadota; Masaru Nasu
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 6.  Fosfomycin: Uses and potentialities in veterinary medicine.

Authors:  D S Pérez; M O Tapia; A L Soraci
Journal:  Open Vet J       Date:  2014-03-16

7.  Fosfomycin suppresses RS-virus-induced Streptococcus pneumoniae and Haemophilus influenzae adhesion to respiratory epithelial cells via the platelet-activating factor receptor.

Authors:  Shin-ichi Yokota; Tamaki Okabayashi; Yuko Yoto; Tsukasa Hori; Hiroyuki Tsutsumi; Nobuhiro Fujii
Journal:  FEMS Microbiol Lett       Date:  2010-06-28       Impact factor: 2.742
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.